No takes yet. Share an insight, caveat, or question.
This vaccine triggers neutralizing antibodies against fusion peptide and V2 apex, suggesting new paths for HIV-1 vaccination.
Duan et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: